申请人:Palmer Abraham
公开号:US11235020B2
公开(公告)日:2022-02-01
Methods and compositions are provided for treating or preventing a neurological disease or disorder using an inhibitor of Glyoxalase 1 (GLO1). In some embodiments, the inhibitor is a small molecule. In certain embodiments, the disease or disorder is a sleep disorder, a mood disorder such as depression, epilepsy, an anxiety disorder, substance abuse, substance dependence or substance such as an alcohol withdrawal syndrome.
本研究提供了使用乙二醛酶 1 (GLO1) 抑制剂治疗或预防神经系统疾病或紊乱的方法和组合物。在某些实施方案中,抑制剂是一种小分子。在某些实施方案中,疾病或紊乱是睡眠障碍、情绪障碍(如抑郁症)、癫痫、焦虑症、药物滥用、药物依赖或药物(如酒精戒断综合征)。